Muscular Dystrophy Treatment & Management: Approach …

Conte G, Gioja L. Scrofola del sistema muscolare. Annali Clinici dell'Ospedale degli Incurabili di Napoli. 1836. 2:66-79.

Meryon E. On granular and fatty degeneration of the voluntary muscles. Medico-Chirurgical Trans. 1852. 35:73-4.

Duchenne GBA. Recherches sur la paralysie musculaire pseudo-hypertrophique ou paralysie myo-sclerosique. Arch Gen Med. 1868. 11:5-25.

Yanagisawa A, Bouchet C, Quijano-Roy S, Vuillaumier-Barrot S, Clarke N, Odent S, et al. POMT2 intragenic deletions and splicing abnormalities causing congenital muscular dystrophy with mental retardation. Eur J Med Genet. 2009 Jul-Aug. 52 (4):201-6. [Medline].

Hoffman EP, Brown RH Jr, Kunkel LM. Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell. 1987 Dec 24. 51 (6):919-28. [Medline].

Waite A, Tinsley CL, Locke M, Blake DJ. The neurobiology of the dystrophin-associated glycoprotein complex. Ann Med. 2009. 41 (5):344-59. [Medline].

Banks GB, Chamberlain JS, Froehner SC. Truncated dystrophins can influence neuromuscular synapse structure. Mol Cell Neurosci. 2009 Apr. 40 (4):433-41. [Medline].

Bushby K. Genetics and the muscular dystrophies. Dev Med Child Neurol. 2000 Nov. 42(11):780-4. [Medline].

Gonzlez-Herrera L, Gamas-Trujillo PA, Garca-Escalante MG, Castillo-Zapata I, Pinto-Escalante D. [Identifying deletions in the dystrophin gene and detecting carriers in families with Duchenne's/Becker's muscular dystrophy]. Rev Neurol. 2009 Jan 16-31. 48(2):66-70. [Medline].

Dickey RP, Ziter FA, Smith RA. Emery-Dreifuss muscular dystrophy. J Pediatr. 1984 Apr. 104 (4):555-9. [Medline].

Miller RG, Layzer RB, Mellenthin MA, Golabi M, Francoz RA, Mall JC. Emery-Dreifuss muscular dystrophy with autosomal dominant transmission. Neurology. 1985 Aug. 35 (8):1230-3. [Medline].

Dobrowski JM, Zajtchuk JT, LaPiana FG, Hensley SD Jr. Oculopharyngeal muscular dystrophy: clinical and histopathologic correlations. Otolaryngol Head Neck Surg. 1986 Sep. 95(2):131-42. [Medline].

Dubowitz V. Muscle Disorders in Childhood. 2nd ed. Philadelphia: WB Saunders; 1995. 34-132.

Emery AEH, Muntoni F, Quinlivan R. Duchenne Muscular Dystrophy (Oxford Monographs on Medical Genetics). 4th ed. Oxford, UK: Oxford University Press; 2015.

Emery AE. Population frequencies of inherited neuromuscular diseases--a world survey. Neuromuscul Disord. 1991. 1 (1):19-29. [Medline].

Shapiro F, Specht L. The diagnosis and orthopaedic treatment of inherited muscular diseases of childhood. J Bone Joint Surg Am. 1993 Mar. 75(3):439-54. [Medline].

Pratt MF, Meyers PK. Oculopharyngeal muscular dystrophy: recent ultrastructural evidence for mitochondrial abnormalities. Laryngoscope. 1986 Apr. 96(4):368-73. [Medline].

Donders J, Taneja C. Neurobehavioral Characteristics of Children with Duchenne Muscular Dystrophy. Child Neuropsychol. 2009 Jan 22. 1-10. [Medline].

Prosser EJ, Murphy EG, Thompson MW. Intelligence and the gene for Duchenne muscular dystrophy. Arch Dis Child. 1969 Apr. 44(234):221-30. [Medline].

Leibowitz D, Dubowitz V. Intellect and behaviour in Duchenne muscular dystrophy. Dev Med Child Neurol. 1981 Oct. 23(5):577-90. [Medline].

Pane M, Lombardo ME, Alfieri P, D'Amico A, Bianco F, Vasco G, et al. Attention deficit hyperactivity disorder and cognitive function in Duchenne muscular dystrophy: phenotype-genotype correlation. J Pediatr. 2012 Oct. 161 (4):705-9.e1. [Medline].

Thompson GH, Berenson FR. Other neuromuscular disorders. Weinstein SL, Flynn JM, eds. Lovell and Winter's Pediatric Orthopaedics. 7th ed. Philadelphia: Lippincott Williams & Wilkins; 2014. 587-628.

Sussman MD. Advantage of early spinal stabilization and fusion in patients with Duchenne muscular dystrophy. J Pediatr Orthop. 1984 Sep. 4(5):532-7. [Medline].

Weimann RL, Gibson DA, Moseley CF, Jones DC. Surgical stabilization of the spine in Duchenne muscular dystrophy. Spine (Phila Pa 1976). 1983 Oct. 8 (7):776-80. [Medline].

Almenrader N, Patel D. Spinal fusion surgery in children with non-idiopathic scoliosis: is there a need for routine postoperative ventilation?. Br J Anaesth. 2006 Dec. 97(6):851-7. [Medline].

Kinali M, Messina S, Mercuri E, Lehovsky J, Edge G, Manzur AY, et al. Management of scoliosis in Duchenne muscular dystrophy: a large 10-year retrospective study. Dev Med Child Neurol. 2006 Jun. 48 (6):513-8. [Medline].

Birnkrant DJ. New challenges in the management of prolonged survivors of pediatric neuromuscular diseases: a pulmonologist's perspective. Pediatr Pulmonol. 2006 Dec. 41(12):1113-7. [Full Text].

Miller RG, Chalmers AC, Dao H, Filler-Katz A, Holman D, Bost F. The effect of spine fusion on respiratory function in Duchenne muscular dystrophy. Neurology. 1991 Jan. 41 (1):38-40. [Medline].

Miller F, Moseley CF, Koreska J, Levison H. Pulmonary function and scoliosis in Duchenne dystrophy. J Pediatr Orthop. 1988 Mar-Apr. 8(2):133-7. [Medline].

Thrush PT, Allen HD, Viollet L, Mendell JR. Re-examination of the electrocardiogram in boys with Duchenne muscular dystrophy and correlation with its dilated cardiomyopathy. Am J Cardiol. 2009 Jan 15. 103(2):262-5. [Medline].

Chamberlain JS, Gibbs RA, Ranier JE. Deletion screening of the Duchenne muscular dystrophy locus via multiplex DNA amplification. Nucleic Acids Res. 1988 Dec 9. 16(23):11141-56. [Medline]. [Full Text].

Miyazaki D, Yoshida K, Fukushima K, Nakamura A, Suzuki K, Sato T, et al. Characterization of deletion breakpoints in patients with dystrophinopathy carrying a deletion of exons 45-55 of the Duchenne muscular dystrophy (DMD) gene. J Hum Genet. 2009 Feb. 54 (2):127-30. [Medline].

Drachman DB, Toyka KV, Myer E. Prednisone in Duchenne muscular dystrophy. Lancet. 1974 Dec 14. 2 (7894):1409-12. [Medline].

Mendell JR, Moxley RT, Griggs RC, Brooke MH, Fenichel GM, Miller JP, et al. Randomized, double-blind six-month trial of prednisone in Duchenne's muscular dystrophy. N Engl J Med. 1989 Jun 15. 320 (24):1592-7. [Medline].

McAdam LC, Mayo AL, Alman BA, Biggar WD. The Canadian experience with long-term deflazacort treatment in Duchenne muscular dystrophy. Acta Myol. 2012 May. 31 (1):16-20. [Medline].

Lebel DE, Corston JA, McAdam LC, Biggar WD, Alman BA. Glucocorticoid treatment for the prevention of scoliosis in children with Duchenne muscular dystrophy: long-term follow-up. J Bone Joint Surg Am. 2013 Jun 19. 95 (12):1057-61. [Medline].

Casey A, Constantin-Teodosiu D, Howell S, Hultman E, Greenhaff PL. Creatine ingestion favorably affects performance and muscle metabolism during maximal exercise in humans. Am J Physiol. 1996 Jul. 271(1 Pt 1):E31-7. [Medline].

Tarnopolsky MA, MacLennan DP. Creatine monohydrate supplementation enhances high-intensity exercise performance in males and females. Int J Sport Nutr Exerc Metab. 2000 Dec. 10(4):452-63. [Medline].

Tarnopolsky MA, Roy BD, MacDonald JR. A randomized, controlled trial of creatine monohydrate in patients with mitochondrial cytopathies. Muscle Nerve. 1997 Dec. 20 (12):1502-9. [Medline].

Chung YL, Alexanderson H, Pipitone N, Morrison C, Dastmalchi M, Sthl-Hallengren C, et al. Creatine supplements in patients with idiopathic inflammatory myopathies who are clinically weak after conventional pharmacologic treatment: Six-month, double-blind, randomized, placebo-controlled trial. Arthritis Rheum. 2007 May 15. 57(4):694-702. [Medline].

Klopstock T, Querner V, Schmidt F, Gekeler F, Walter M, Hartard M, et al. A placebo-controlled crossover trial of creatine in mitochondrial diseases. Neurology. 2000 Dec 12. 55(11):1748-51. [Medline].

Louis M, Lebacq J, Poortmans JR, Belpaire-Dethiou MC, Devogelaer JP, Van Hecke P, et al. Beneficial effects of creatine supplementation in dystrophic patients. Muscle Nerve. 2003 May. 27(5):604-10. [Medline].

Kley RA, Tarnopolsky MA, Vorgerd M. Creatine for treating muscle disorders. Cochrane Database Syst Rev. 2011 Feb 16. 2:CD004760. [Medline].

Hamed SA. Drug evaluation: PTC-124--a potential treatment of cystic fibrosis and Duchenne muscular dystrophy. IDrugs. 2006 Nov. 9(11):783-9. [Medline].

DMD-ataluren (Translarna), for genetic disorders. PTC Therapeutics. Available at http://www.ptcbio.com/en/pipeline/ataluren-translarna/ataluren-faq/. 2019; Accessed: December 16, 2019.

Cirak S, Arechavala-Gomeza V, Guglieri M, Feng L, Torelli S, Anthony K, et al. Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study. Lancet. 2011 Aug 13. 378 (9791):595-605. [Medline].

Vyondys 53 (golodirsen) [package insert]. Cambridge, MA: Sarepta Therapeutics. December 2019. Available at [Full Text].

Ragot T, Vincent N, Chafey P, Vigne E, Gilgenkrantz H, Couton D, et al. Efficient adenovirus-mediated transfer of a human minidystrophin gene to skeletal muscle of mdx mice. Nature. 1993 Feb 18. 361 (6413):647-50. [Medline].

Wang Z, Allen JM, Riddell SR, Gregorevic P, Storb R, Tapscott SJ, et al. Immunity to adeno-associated virus-mediated gene transfer in a random-bred canine model of Duchenne muscular dystrophy. Hum Gene Ther. 2007 Jan. 18 (1):18-26. [Medline].

Howell JM, Lochmller H, O'Hara A, Fletcher S, Kakulas BA, Massie B, et al. High-level dystrophin expression after adenovirus-mediated dystrophin minigene transfer to skeletal muscle of dystrophic dogs: prolongation of expression with immunosuppression. Hum Gene Ther. 1998 Mar 20. 9 (5):629-34. [Medline].

Griggs RC, Karparti G, eds. Myoblast Transfer Therapy (Advances in Experimental Medicine and Biology). Dordrecht, Netherlands: Kluwer Academic Publishers; 1990.

Rando TA. Non-viral gene therapy for Duchenne muscular dystrophy: Progress and challenges. Biochim Biophys Acta. 2007 Feb. 1772(2):263-71. [Medline].

Wells DJ. Therapeutic restoration of dystrophin expression in Duchenne muscular dystrophy. J Muscle Res Cell Motil. 2006. 27(5-7):387-98. [Medline].

Judge LM, Chamberlain JS. Gene therapy for Duchenne muscular dystrophy: AAV leads the way. Acta Myol. 2005 Dec. 24(3):184-93. [Medline].

Gurpur PB, Liu J, Burkin DJ, Kaufman SJ. Valproic acid activates the PI3K/Akt/mTOR pathway in muscle and ameliorates pathology in a mouse model of Duchenne muscular dystrophy. Am J Pathol. 2009 Mar. 174 (3):999-1008. [Medline].

Brooke MH, Fenichel GM, Griggs RC, Mendell JR, Moxley R, Florence J, et al. Duchenne muscular dystrophy: patterns of clinical progression and effects of supportive therapy. Neurology. 1989 Apr. 39 (4):475-81. [Medline].

Heckmatt JZ, Dubowitz V, Hyde SA, Florence J, Gabain AC, Thompson N. Prolongation of walking in Duchenne muscular dystrophy with lightweight orthoses: review of 57 cases. Dev Med Child Neurol. 1985 Apr. 27 (2):149-54. [Medline].

Drennan J. Neuromuscular disorders. Lowell WW, Morrissy RT, Winter RB, eds. Lovell and Winter's Pediatric Orthopaedics. 3rd ed. Philadelphia: Lippincott Williams & Wilkins; 1990. 381.

Yount CC. The role of tensor fascia femoris in certain deformities of the lower extremities. J Bone Joint Surg. 1926. 8:171-93.

Suk KS, Lee BH, Lee HM, Moon SH, Choi YC, Shin DE, et al. Functional outcomes in Duchenne muscular dystrophy scoliosis: comparison of the differences between surgical and nonsurgical treatment. J Bone Joint Surg Am. 2014 Mar 5. 96 (5):409-15. [Medline].

Brooks JT, Sponseller PD. What's New in the Management of Neuromuscular Scoliosis. J Pediatr Orthop. 2016 Sep. 36 (6):627-33. [Medline].

Jain A, Hassanzadeh H, Strike SA, Menga EN, Sponseller PD, Kebaish KM. Pelvic Fixation in Adult and Pediatric Spine Surgery: Historical Perspective, Indications, and Techniques: AAOS Exhibit Selection. J Bone Joint Surg Am. 2015 Sep 16. 97 (18):1521-8. [Medline].

Gaine WJ, Lim J, Stephenson W, Galasko CS. Progression of scoliosis after spinal fusion in Duchenne's muscular dystrophy. J Bone Joint Surg Br. 2004 May. 86 (4):550-5. [Medline].

Sengupta DK, Mehdian SH, McConnell JR, Eisenstein SM, Webb JK. Pelvic or lumbar fixation for the surgical management of scoliosis in duchenne muscular dystrophy. Spine (Phila Pa 1976). 2002 Sep 15. 27 (18):2072-9. [Medline].

Mubarak SJ, Morin WD, Leach J. Spinal fusion in Duchenne muscular dystrophy-fixation and fusion to the sacropelvis?. J Pediatr Orthop. 1993 Nov-Dec. 13(6):752-7. [Medline].

Tian C, Wong B, Hornung L, et al. G.P.171: Age-specific prevalence of osteoporosis and frequency of poor bone health indices in Duchenne Muscular Dystrophy. Neuromuscul Disord. 2014 Oct. 24 (9-10):857.

Singh A, Schaeffer EK, Reilly CW. Vertebral Fractures in Duchenne Muscular Dystrophy Patients Managed With Deflazacort. J Pediatr Orthop. 2018 Jul. 38 (6):320-324. [Medline].

Buckner JL, Bowden SA, Mahan JD. Optimizing Bone Health in Duchenne Muscular Dystrophy. Int J Endocrinol. 2015. 2015:928385. [Medline]. [Full Text].

[Guideline] Noritz GH, Murphy NA, Neuromotor Screening Expert Panel. Motor delays: early identification and evaluation. Pediatrics. 2013 Jun. 131 (6):e2016-27. [Medline]. [Full Text].

Muscular dystrophy: diagnostic tools. Centers for Disease Control and Prevention. Available at http://www.cdc.gov/ncbddd/musculardystrophy/diagnostic-tool.html. December 2, 2019; Accessed: December 16, 2019.

Early diagnosis makes a difference. ChildMuscleWeakness.org. Available at http://www.childmuscleweakness.org/index.php. 2019; Accessed: December 16, 2019.

[Guideline] Bushby K, Finkel R, Birnkrant DJ, Case LE, Clemens PR, Cripe L, et al. Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management. Lancet Neurol. 2010 Jan. 9 (1):77-93. [Medline]. [Full Text].

[Guideline] Bushby K, Finkel R, Birnkrant DJ, Case LE, Clemens PR, Cripe L, et al. Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care. Lancet Neurol. 2010 Feb. 9 (2):177-89. [Medline]. [Full Text].

[Guideline] Birnkrant DJ, Panitch HB, Benditt JO, Boitano LJ, Carter ER, Cwik VA, et al. American College of Chest Physicians consensus statement on the respiratory and related management of patients with Duchenne muscular dystrophy undergoing anesthesia or sedation. Chest. 2007 Dec. 132 (6):1977-86. [Medline]. [Full Text].

[Guideline] Tawil R, Kissel JT, Heatwole C, et al. Evidence-based guideline summary: Evaluation, diagnosis, and management of facioscapulohumeral muscular dystrophy: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the Practice Issues Review Panel of the American Association of Neuromuscular & Electrodiagnostic Medicine. Neurology. 2015 Jul 28. 85 (4):357-64. [Medline]. [Full Text].

[Guideline] Wang CH, Bonnemann CG, Rutkowski A, et al, International Standard of Care Committee for Congenital Muscular Dystrophy. Consensus statement on standard of care for congenital muscular dystrophies. J Child Neurol. 2010 Dec. 25 (12):1559-81. [Medline]. [Full Text].

[Guideline] Kang PB, Morrison L, Iannaccone ST, et al, Guideline Development Subcommittee of the American Academy of Neurology and the Practice Issues Review Panel of the American Association of Neuromuscular & Electrodiagnostic Medicine. Evidence-based guideline summary: evaluation, diagnosis, and management of congenital muscular dystrophy: Report of the Guideline Development Subcommittee of the American Academy of Neurology and the Practice Issues Review Panel of the American Association of Neuromuscular & Electrodiagnostic Medicine. Neurology. 2015 Mar 31. 84 (13):1369-78. [Medline]. [Full Text].

[Guideline] Narayanaswami P, Weiss M, Selcen D, et al, Guideline Development Subcommittee of the American Academy of Neurology, Practice Issues Review Panel of the American Association of Neuromuscular & Electrodiagnostic Medicine. Evidence-based guideline summary: diagnosis and treatment of limb-girdle and distal dystrophies: report of the guideline development subcommittee of the American Academy of Neurology and the practice issues review panel of the American Association of Neuromuscular & Electrodiagnostic Medicine. Neurology. 2014 Oct 14. 83 (16):1453-63. [Medline]. [Full Text].

Read the rest here:
Muscular Dystrophy Treatment & Management: Approach ...